- Home
- ALGS vs ZBAO Comparison
ALGS vs ZBAO Comparison
Compare ALGS & ZBAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- ZBAO
- Stock Information
- Founded
- ALGS 2018
- ZBAO 2015
- Country
- ALGS United States
- ZBAO China
- Employees
- ALGS N/A
- ZBAO N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- ZBAO
- Sector
- ALGS Health Care
- ZBAO
- Exchange
- ALGS Nasdaq
- ZBAO NYSE
- Market Cap
- ALGS 36.0M
- ZBAO 34.5M
- IPO Year
- ALGS 2020
- ZBAO 2024
- Fundamental
- Price
- ALGS $7.14
- ZBAO $1.02
- Analyst Decision
- ALGS Strong Buy
- ZBAO
- Analyst Count
- ALGS 1
- ZBAO 0
- Target Price
- ALGS $70.00
- ZBAO N/A
- AVG Volume (30 Days)
- ALGS 135.0K
- ZBAO 130.0K
- Earning Date
- ALGS 08-05-2025
- ZBAO 04-15-2025
- Dividend Yield
- ALGS N/A
- ZBAO N/A
- EPS Growth
- ALGS N/A
- ZBAO N/A
- EPS
- ALGS N/A
- ZBAO 0.09
- Revenue
- ALGS $3,270,000.00
- ZBAO $33,673,520.00
- Revenue This Year
- ALGS N/A
- ZBAO $65.08
- Revenue Next Year
- ALGS $51.55
- ZBAO $34.27
- P/E Ratio
- ALGS N/A
- ZBAO $10.98
- Revenue Growth
- ALGS N/A
- ZBAO 82.66
- 52 Week Low
- ALGS $3.76
- ZBAO $0.84
- 52 Week High
- ALGS $46.80
- ZBAO $4.27
- Technical
- Relative Strength Index (RSI)
- ALGS 50.99
- ZBAO N/A
- Support Level
- ALGS $7.11
- ZBAO N/A
- Resistance Level
- ALGS $8.66
- ZBAO N/A
- Average True Range (ATR)
- ALGS 0.88
- ZBAO 0.00
- MACD
- ALGS -0.02
- ZBAO 0.00
- Stochastic Oscillator
- ALGS 38.79
- ZBAO 0.00
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About ZBAO ZHIBAO TECHNOLOGY INC
Zhibao Technology Inc is a insurance technology company engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their business model which is pioneered in China. It provides customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.